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Abstract
Background: The epidemiologic literature is replete with conceptual discussions about causal
inference, but little is known about how the causal criteria are applied in public health practice. The
criteria for causal inference in use today by epidemiologists have been shaped substantially by their
use over time in reports of the U.S. Surgeon General on Smoking and Health.
Methods: We reviewed two classic reports on smoking and health from expert committees
convened by the US Surgeon General, in 1964 and 1982, in order to evaluate and contrast how the
committees applied causal criteria to the available evidence for the different cancer sites at different
time periods. We focus on the evidence for four cancer sites in particular that received detailed
reviews in the reports: lung, larynx, esophagus and bladder.
Results:  We found that strength of association and coherence (especially dose-response,
biological plausibility and epidemiologic sense) appeared to carry the most weight; consistency
carried less weight, and temporality and specificity were apparently not applied at all in some cases.
No causal claim was made for associations with a summary odds ratio of less than 3.0.
Conclusion: Our findings suggest that the causal criteria as described in textbooks and the
Surgeon General reports can have variable interpretations and applications in practice. While the
authors of these reports may have considered evidential factors that they did not explicitly cite,
such lack of transparency of methods undermines the purpose of the causal criteria to promote
objective, evidence-based decision making. Further empirical study and critical examination of the
process by which causal conclusions are reached can play an important role in advancing the
practice of epidemiology by helping public health scientists to better understand the practice of
causal inference.
Forty years ago, the release of the Surgeon General's report
on Smoking and Health marked a turning point in scientific
and public health efforts to address the consequences of
tobacco use for human health [1]. There had been earlier
statements by the U.S. Surgeon General, in 1957 and
1959, declaring cigarette smoking to be an important
cause of lung cancer [2,3], and there had been previous
independent expert committees who reviewed the mass of
available evidence and reached similar conclusions [4,5].
Nevertheless, the 1964 report became a landmark in the
history of evidence-based public health because of its
Published: 10 January 2006
Emerging Themes in Epidemiology 2006, 3:1 doi:10.1186/1742-7622-3-1
Received: 27 June 2005
Accepted: 10 January 2006
This article is available from: http://www.ete-online.com/content/3/1/1
© 2006 Parascandola et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Emerging Themes in Epidemiology 2006, 3:1 http://www.ete-online.com/content/3/1/1
Page 2 of 11
(page number not for citation purposes)
explicit use of pre-stated criteria for causal inference – con-
sistency, strength, specificity, temporality, and coherence.
Essentially the same criteria are in wide use by epidemiol-
ogists today, and the report is frequently cited, along with
Austin Bradford Hill's 1965 list of criteria [6], as a basis for
causal inference in textbooks, literature reviews and con-
sensus documents [7]. The history of scientific responses
to the evidence linking cigarette smoking to various
adverse health outcomes, particularly cancer, serves as a
unique model case for understanding the evolution of
contemporary epidemiologic practice. While the disci-
pline of epidemiology has developed new quantitative
methods and research tools in recent decades, the applica-
tion of the causal criteria today has been shaped substan-
tially by their early use in evaluating the evidence on
smoking and health. However, while there has been con-
siderable theoretical discussion of causal inference among
epidemiologists over the years [8], there has been little
effort to study how these criteria have been actually
applied in practice. The most recent Surgeon General's
report on the health consequences of smoking devotes an
entire chapter to the changing causal language and con-
clusions across the reports, but the chapter does not
include empirical analysis of why  those conclusions
changed (i.e. what were the key factors in the evidence
that supported new, stronger causal conclusions?) [9].
In order to observe and understand how the causal criteria
were applied to diverse bodies of evidence over time, we
conducted a case study of the use of causal criteria in two
reports of the Surgeon General on smoking and health,
from 1964 and 1982. We reviewed the evidence available
to the committees that authored these reports as well as
the application of the causal criteria in the reports to the
relationship between cigarette smoking and four cancers:
lung, laryngeal, esophageal, and bladder. In addition to
their historical interest, these reports allow us to observe
how two expert panels with a common mandate apply
identical, pre-stated inferential criteria to the same ques-
tions as the evidence accumulates over time. Additionally,
this particular example allows us to focus on the process
of causal inference because, while judgments about the
relationship between smoking and these four cancers
changed over time, each of these cancers has since been
clearly linked to smoking [10].
Committees and causal criteria
By the early 1960s there were already two statements from
the Surgeon General and at least two consensus state-
ments from groups of public health scientists concluding
that the evidence was sufficient to claim that cigarette
smoking was a cause of lung cancer [2,3]. In 1957, the
Study Group on Smoking and Health, including members
of the American Cancer Society, the American Heart Asso-
ciation, the National Cancer Institute (NCI) and the
National Heart Institute concluded that "The sum total of
scientific evidence establishes beyond a reasonable doubt
that cigarette smoking is a causative factor in the rapidly
increasing incidence of human epidermoid carcinoma of
the lung." [11] Two years later, a follow up review pre-
pared by a group of leading epidemiologists and biostat-
isticians (including Jerome Cornfield, William Haenszel,
Michael Shimkin, E. Cuyler Hammond, Abraham Lilien-
feld and Ernst Wynder) took account of the growing pool
of cohort data and responded in substantial detail to var-
ious critiques that had been offered of the evidence. They
admitted that the questions were not closed to further
study, but they urged that "[t]he doctrine that one must
never assess what has already been learned until the last
possible piece of evidence [is in] would be a novel one for
science." The fact that more could be learned did not pre-
clude making judgments, and if it were not for the power
of tobacco and the tobacco industry, the evidence "would
be generally be regarded as beyond dispute." [12] Simi-
larly, the Surgeon General released official statements on
smoking and health in 1957 and 1959 declaring first that
"the evidence is increasingly pointing in one direction:
that excessive cigarette smoking is one of the causative fac-
tors in lung cancer" [2] and later that smoking is "the prin-
ciple [sic] etiological factor in the increasing incidence of
lung cancer."[3]
These reviews applied similar criteria to those applied in
the 1964 Surgeon General's report. Robert Koch's postu-
lates had previously provided a framework for identifying
causes of infectious diseases, but those postulates, which
required isolation of a parasite and inducing the disease in
the laboratory, had limited application for environmental
causes of chronic diseases. Thus, as the evidence linking
smoking and lung cancer developed during the 1950s,
public health scientists debated the requirements for dem-
onstrating causation, and criteria proposed during these
debates were later used in the 1964 report [7,13].
On June 1, 1961, the American Cancer Society, the Amer-
ican Heart Association, the American Public Health Asso-
ciation, and the National Tuberculosis Association sent a
joint letter to President Kennedy asking for the appoint-
ment of a special commission to address the need for gov-
ernment action on smoking and health. They urged that
the evidence of harm was sufficient to require government
intervention [14,15]. However, health leaders in the
Kennedy Administration were initially reluctant to take
action, responding that disagreement remained over how
much of the lung cancer burden could be attributed to
smoking and could, in turn, be prevented by smoking
reduction efforts [16-18]. Thus, Surgeon General Luther
Terry decided that what was needed first was a compre-
hensive review of all the data on smoking and health byEmerging Themes in Epidemiology 2006, 3:1 http://www.ete-online.com/content/3/1/1
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an expert advisory committee. While public health activ-
ists saw this move as another delaying tactic [19], Terry
understood the value of an irreproachable view of the sci-
ence. Thus, the committee would provide an "objective
assessment of the nature and magnitude of the health haz-
ard," but would not conduct new research or make any
policy recommendations [1].
Selection of the committee members was a crucial part of
the process to create an authoritative committee. The 10
committee members were selected from a list of about
150 physicians and biomedical scientists who had not
taken a prior public position on the smoking and health
issue. Major medical associations, volunteer public health
organizations, the Tobacco Institute, the Food and Drug
Administration, the Federal Trade Commission and the
President's Office of Science and Technology were all
given the opportunity to delete anyone from the list for
any reason. President Kennedy himself promised that
there would be no political interference with the commit-
tee's work [20]. None of the scientists who had conducted
studies of smoking and health and been active in earlier
debates, such as Cuyler Hammond and Ernst Wynder,
ended up on the committee. Of the ten members, all but
two were medical doctors. Their expertise included
pathology, surgery, chemistry, cancer biology, internal
medicine, pharmacology, statistics, and epidemiology.
Given the importance that the epidemiologic evidence
took on in the inquiry, it is important to note that the
committee included only one epidemiologist and one
biostatistician (Table 1) [1].
The committee members held their first meeting at the
National Library of Medicine in Bethesda, Maryland, on
November 9, 1962, with their deliberations under strict
secrecy [21]. Outside communication with the committee
members was controlled. Unfortunately, there is little
remaining documentation of the committee's process and
deliberations. Records of the Committee at the National
Archives do not include formal meeting minutes that
might characterize the group's discussions [22]. Accounts
of the committee's deliberations and process are largely
anecdotal [23]. Additionally, no minority report was pro-
duced.
The 1964 committee was unique both in its process and
in the degree of attention given to it. Over the years, the
process for producing Surgeon Generals' reports changed
as well. The 1982 report, The Health Consequences of Smok-
ing: Cancer, was assembled by an editorial committee of
scientists, and individual chapters were authored by small
groups of a few experts with multiple layers of review. The
largest chapter, Biomedical Evidence for Determining Causal-
ity, was written by respiratory medicine specialist Richard
Bordow and epidemiologist Abraham Lilienfeld [24].
Many of the authors and reviewers were actively working
on research related to smoking and health at the time. By
this time, the key challenges facing the scientists were not
whether smoking was a cause of lung cancer, but the
extent of its effects on both smokers and nonsmokers, the
potential benefits of low tar cigarettes and the success of
smoking cessation efforts. Nevertheless, the criteria for
causality that were applied were the same as those applied
in the 1964 report.
Methods
Two reports of the Surgeon General on smoking and
health that applied causal criteria to the four cancers at
different points in time (1964 and 1982) [1,24] form the
basis of our investigation. We chose these two reports
because they applied the same causal criteria yet also rep-
resent a time period during which evidence linking smok-
ing and some cancers was growing substantially. We chose
to examine the evidence for the causal role of smoking in
the development of cancer at four sites in particular for
which there was adequate evidence available to apply the
causal criteria: lung, larynx, esophagus, and bladder.
Both the 1964 and 1982 reports documented their evalu-
ation of causality using the same five causal criteria: con-
sistency, strength, specificity, temporal relationship, and
coherence. Coherence was a broad category that assessed
Table 1: 1964 Report: Members of the Advisory Committee to the U.S. Surgeon General
Name and Degrees Discipline
Stanhope Bayne-Jones, M.D., LL.d., Bacteriology, Public Health
Walter J. Burdette, M.D., Ph. D., Surgery, Genetics
William G. Cochran, M.A., Statistics
Emmanuel Farber, M.D., Ph. D., Pathology
Louis F. Fieser, Ph. D., Chemistry
Jacob Furth, M.D., Cancer Biology
John B. Hickam, M.D., Internal Medicine (cardiopulmonary disease)
Charles LeMaistre, M.D., Internal Medicine (pulmonary diseases)
Leonard M. Schuman, M.D., Epidemiology
Maurice H. Seevers, M.D., Ph. D., PharmacologyE
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Table 2: Summary of evidence extracted from two Surgeon General reports
1964 1982
Lung Laryngeal Esophageal Bladder Esophageal Bladder
Consistency: CC 24 studies/24 positive 10 studies/10 positive 6 studies/6 positive 4 studies/4 positive 9 studies/All positive 10 studies/8 positive
Consistency: 
Cohort
7 Studies/7 positive 7 studies/4 positive, 3 neutral 7 studies/6 positive, 1 negative 7 studies/6 positive, 1 negative 7 studies/All positive 8 studies/All positive
Strength: CC 5.43 (95% CI: 4.82 – 6.11) 4.52 (95% CI: 3.69 – 5.53) 2.38 (95% CI: 1.62 – 3.49) 2.28 (95% CI: 1.79 – 2.89) 3.11 (95% CI: 2.54 – 3.81) 2.02 (95% CI: 1.74 – 2.34)
Strength: Cohort 10.8 (range: 4.9 – 20.2) 5.4 (range: 1.5 – 13.1) 3.4 (range: .7 – 6.6) 1.9 (range: 0.9 – 6.0) Range: 1.8 – 6.4 Prospective Studies: 1.4 – 2.9
Specificity "90% [of lung cancer] is 
associated with cigarette 
smoking."(184) "the number of 
disease in which the ratios 
remain significantly high ... is 
not so great as to cast serious 
doubt on the causal 
hypothesis."(185)
Not stated Not stated Not stated "Specificity ... is evidenced by 
substantial differences in the 
mortality ratios ... for 
esophageal cancer compared 
to other smoking related 
cancers."(96)
"lower order of ... specificity 
for bladder cancer than for 
cancers of the lung, larynx, oral 
cavity or esophagus suggests 
that factors other than smoking 
may be associated etiologically 
with bladder cancer."(108)
Temporality "The early exposure to 
tobacco smoke and late 
manifestation of lung cancer 
among smokers, seem, at least 
superficially, to fulfill this 
condition." (185)
Not stated Not stated Not stated "The temporal relationship of 
the association is supported by 
the prospective studies" "In 
addition, there are histological 
data suggesting that smoking 
predates premalignant and 
malignant transformation." (97)
"Evidence for the temporal 
relationship of the association 
is provided by the prospective 
studies" "Reliable histological 
studies of bladder epithelium in 
smokers compared with 
nonsmokers have not been 
reported."(110)
Dose Response "In almost every study for 
which data were adequate" a 
gradient was observed with 
amount of smoking, duration, 
age when started, ex smokers, 
and inhalation
Gradient also observed with 
increased amounts of smoking 
and inhalation. "The parallelism 
with lung cancer, though not as 
complete because of a smaller 
amount of material, is 
remarkable."
Pooled cohort data revealed 
gradient for heavy versus 
moderate smokers. Gradient 
with amount smoked observed 
in only two of seven case 
control studies.
Pooled cohort data revealed 
gradient for heavy versus 
moderate smokers. Gradient 
with amount smoked observed 
in only two of four case 
control studies.
Dose response observed in 
retrospective and prospective 
studies
Modest dose response 
"however this relationship is 
not as strong as that noted 
between smoking and lung, 
laryngeal, oral, and esophageal 
cancers."(108)
Biologic 
Plausibility: 
Animal/Lab 
Studies
Application of tobacco smoke 
or condensates to lungs or 
tracheobronchial tree in 
animals failed to induce lung 
tumors (except possibly in 
dogs) [106, 248, 206, 224, 
205a, 273, 274, 275, 29, 289]
"No attempts to induce 
carcinoma of the larynx by 
tobacco smoker or smoke 
condensates have been 
reported."(210)
"No attempts to induce 
carcinoma of the esophagus by 
tobacco smoker or smoke 
condensates have been 
reported."(217)
Three teams of investigators 
have studied bladder cancer in 
mice treated with tobacco tars, 
but findings were inconsistent 
and their significance unclear 
[177, 75, 295]
"There is experimental 
evidence that benzo[a]pyrene 
is able to penetrate the cell 
membranes of the esophageal 
epithelium," producing 
papillomas and carcinoma.(101)
Not stated
Biologic 
Plausibility: 
Human Pathology
Histopathologic changes in 
lungs of smokers in a 
controlled blind study of 402 
male patients
Histopathologic changes in 
larynx of smokers(271)
Not Stated Not Stated Examination of autopsy tissue 
from 1,268 men showed 
atypical cells much more 
common in smokers
[see temporality above]
Biologic 
Plausibility: 
Localization of 
cancer
"Localization of cancer in 
relation to type of 
smoking"(188)
"Localization of lesions"(210) Not Stated Not States Not Stated Not Stated
Coherence Time Trends Sex Differential 
Urban-rural differences Socio-
economic differential
Time Trends Sex Differential "Mortality from esophageal 
cancer in the United States had 
shown a tendency to rise 
slightly among whites in the last 
30 years."(218)
"information is lacking for an 
intelligent discussion of the sex 
differential" "urban rural 
differential is virtually non-
existent"(225)
Sex differential Lower 
mortality rates in low smoking 
populations (Mormons and 7th 
Day Adventists) Lower risk in 
ex-smokers Smoking acts 
synergistically in combination 
with alcohol.
Sex differential Lower 
mortality rates in low smoking 
populations (Mormons and 7th 
Day Adventists) Lower risk in 
ex-smokers Occupational 
exposures associated with 
bladder cancer
Causal? Yes Yes No No Yes No
Numbers in parentheses are references to page numbers in the Surgeon General reportsEmerging Themes in Epidemiology 2006, 3:1 http://www.ete-online.com/content/3/1/1
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whether all the evidence makes sense taken together,
including information about dose response, mortality
trends, and biologic plausibility. Definitions given for
these criteria are essentially the same in both reports,
although the definitions provided in the 1982 report are
more thorough. However, our interpretation of the appli-
cation of the causal criteria relies largely on descriptions
provided in the reports. Official records in the National
Archives from the Surgeon General's Advisory Committee
on Smoking and Health, which authored the 1964 report,
did not yield additional details about the committee's
causal reasoning. [25]
In both reports, cohort mortality and case-control study
data were available for all cancers. In order to clearly sum-
marize the case-control evidence available to the 1964
and 1982 committees, we conducted our own pooled
analysis of the case-control data. While the two commit-
tees did not make use of formal, quantitative meta-ana-
lytic tools to assess the case control data, we do so for the
purpose of representing the body of data in a straightfor-
ward manner to the reader who may not be as familiar
with the data as the authors of the reports were. We follow
the Surgeon General reports in discussing case-control
and cohort data separately rather than pooling different
types of studies together. The reports did not provide p-
values or confidence intervals when summarizing data,
and they did not consistently report whether or not posi-
tive results were statistically significant. We did not con-
duct a similar pooled analysis for the cohort data because
some of these studies were not yet published at the time;
although the Committee had access to the raw data for
some studies, these were not available to us. However, the
1964 report included a simple unadjusted pooled analysis
of cohort data upon which we draw.
We obtained all original research papers for the case-con-
trol studies cited in the reports as studies of cigarette
smoking and the four cancers. We conducted meta-analy-
ses on the published data from the case-control studies
using the DerSimonian-Laird method [26]. We excluded
the case-control studies that included only women, since
the smoking habits for men and women were quite differ-
ent at the time, and we excluded studies that did not
report numbers of cases and controls and numbers of
smokers and nonsmokers within these groups, as these
did not allow calculation of an odds ratio; for example,
some papers only reported percentages or ratios without
providing the actual numbers used to calculate them.
Seven out of 61 studies (11%) were excluded for insuffi-
cient data. The studies included employed a diverse range
of data collection and reporting procedures to describe
smoking status; in this study comparisons were made only
between smokers and non-smokers. Estimates were not
adjusted for age or other potential confounders.
Separate meta-analyses were conducted for each cancer
site, namely lung, esophagus, larynx and bladder, and
summary odds ratios and confidence intervals were
obtained. Additionally, separate meta-analyses were con-
ducted for bladder and esophageal cancer for those stud-
ies included in the 1964 report and those included in the
1982 report. Each of the six meta-analyses was summa-
rized graphically by boxplots showing the summary odds
ratio and confidence interval for each meta-analysis.
Results
The 1964 report concluded that there was sufficient evi-
dence to regard cigarette smoking as a cause of both lung
and laryngeal cancer (in men), but not of esophageal and
bladder cancer. In contrast, the 1982 report concluded
that cigarette smoking was a cause of esophageal cancer,
but that the evidence remained insufficient for bladder
cancer. Here we describe the evidence that was available
for six causal assessments, focusing on comparisons
between different types of cancer in the same report, and
between reports for the same cancer type. These compara-
tive analyses allow us to study how different bodies of evi-
dence can result in different judgments about causation.
The evidence cited in the reports for each of these causal
assessments is described in Table 2. Results from our
pooled analysis of the case-control studies are presented
in Figure 1.
Lung cancer
The initial interest into the potential carcinogenic effect of
smoking focused on lung cancer, because lung cancer
mortality rates were increasing dramatically. Thus, as
explained in the 1964 report, far more studies had been
conducted of lung cancer (and far more deaths observed)
than for the other cancers. The 1964 Surgeon General's
report discussed lung cancer first and devoted more than
five times as much space to it than for any of the other
cancers. Much of the discussion responded to specific crit-
icisms that had been raised in prior scientific debates
about the growing evidence on smoking and health [5].
The summary odds ratio from 25 case-control studies was
5.43 (95% CI: 4.82 – 6.11). All but two of the studies
reported statistically significant positive associations,
although the odds ratios for the individual case-control
studies varied widely, from 0.8 to 35.4. The report pro-
vided a summary mortality ratio from the seven cohort
studies of 10.8 (range: 4.9 – 20.2). Two prospective stud-
ies of tobacco workers that had not found any increased
mortality among smokers were dismissed by the Surgeon
General's committee because of "major defects". These
studies, conducted by the American Tobacco Company,
compared disease rates in a heavy smoking population of
tobacco workers with those of the general population,
thus being vulnerable to the "healthy worker" effect, andEmerging Themes in Epidemiology 2006, 3:1 http://www.ete-online.com/content/3/1/1
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did not have individual level information on smoking sta-
tus [27,28].
While the cohort studies linked cigarette smoking to
numerous diseases, the committee concluded that the
specificity criterion was met for lung cancer because the
strength of association was so much greater than for other
diseases, and because they reasoned that the majority of
lung cancers were attributable to smoking (based on the
magnitude of the relative risk) [[1], p. 184].
The report devoted more space to addressing coherence
than to any other criterion for causal inference. Studies of
mortality trends revealed a correlation between lung can-
cer death rates and cigarette consumption in different
countries, a dramatic rise in lung cancer mortality follow-
ing a World War I increase in cigarette consumption, and
higher mortality in men and urban populations consist-
ent with smoking patterns. Five of the cohort studies pro-
vided sufficient data to demonstrate a dose-response
trend for increasing amounts of smoking. The plausibility
of causation was enhanced by the fact that the lung is
directly in the exposure pathway. Pathology studies of cel-
lular changes in the tracheobronchial tree of male patients
at autopsy revealed that an increasing amount of smoking
correlated with a higher percentage of atypical cells, inter-
preted as precursors to lung cancer. Evidence from animal
studies, however, was lacking. Application of tobacco tars
to the lungs and trachea of animals in ten studies yielded
results that were negative or of "uncertain significance".
Contrast between laryngeal and lung cancers in 1964
While the 1964 report gave the most attention to lung
cancer, a positive causal conclusion was also made for
laryngeal cancer. The summary odds ratio from 10 case-
control studies of smoking and laryngeal cancer, all statis-
tically significantly positive, was 4.52 (95% CI: 3.69 –
5.53), and the summary mortality ratio from seven cohort
studies was 5.4 (range: 1.5 – 13.1). Thus, studies of both
lung and laryngeal cancers exhibited summary relative
risks greater than 4.0 in both case-control and cohort
studies. For laryngeal cancer, all of the case-control studies
and four of seven cohort studies showed statistically sig-
nificant positive associations. However, fewer data were
available to evaluate coherence (including dose-response
trends) for laryngeal cancer and smoking, as only 10 case-
control studies had been conducted of laryngeal cancer
(compared with 24 for lung cancer) and there were only a
total of 75 laryngeal cancer deaths (compared with 1833
for lung cancer) in all the cohort studies. No mention was
made of specificity and temporality for laryngeal cancer in
the report.
Contrast between laryngeal and esophageal cancers in 
1964
Although the 1964 Committee concluded that smoking
was a cause of laryngeal cancer, it did not ascribe causality
for esophageal cancer. What accounted for this difference?
The summary odds ratio from six case-control studies of
smoking and esophageal cancer was 2.38 (95% CI: 1.62 –
3.49) and the report's summary mortality ratio from seven
cohort studies was 3.4 (range: 0.7 – 6.6). The one negative
result was dismissed by the Committee because it was
based on only four deaths, too few to be a stable estimate.
Although a dose-response trend was seen in only two of
seven case-control studies, a trend was seen in the com-
bined cohort study data. The report did not cite any
human pathology or animal studies. Mortality statistics
revealed a slight rise in esophageal cancer over the previ-
ous three decades. Compared with laryngeal cancer, the
evidence for esophageal cancer, as described in the report,
came from fewer studies, showed a lower level of strength,
a similar if not slightly increased level of consistency, and
less coherence. In particular, the report noted the "small-
ness" of the rise in esophageal cancer mortality following
increased smoking prevalence and the limited dose-
response data.
Contrast between esophageal and bladder cancers in 1964
We looked at the similarities and differences in the evi-
dence for esophageal and bladder cancer in 1964, when
no causal relationship was inferred for either. For bladder
cancer there were only four case-control studies, with a
summary odds ratio of 2.28 (95% CI: 1.79 – 2.89),
though all were statistically significantly positive. The
report provided a summary mortality ratio from seven
cohort studies of 1.9 (range: 0.9 – 6.0). Again, the one
negative result was dismissed by the Committee because
it was based on too few deaths to be a stable estimate. A
dose-response trend was only seen in two of four case-
control studies and in the combined cohort study data.
Studies of bladder cancers in mice treated with tobacco
tars were inconsistent, and no human pathology studies
were cited. The report noted that mortality trends did not
suggest any sex differential or urban-rural difference con-
sistent with smoking patterns. No mention was made of
localization of lesions in the report. Compared with
esophageal cancer, the evidence for bladder cancer dem-
onstrated a lower level of strength, consistency, and coher-
ence.
Esophageal cancer: 1964 and 1982
As a causal claim was made for esophageal cancer in 1982
but not in 1964, we examined the impact of the evidence
accumulated between the two reports. The summary odds
ratio for 1982, based on three more case-control studies
(for a total of 9), was 3.11 (95% CI: 2.54 – 3.81), and all
but two of the studies reported statistically significant pos-Emerging Themes in Epidemiology 2006, 3:1 http://www.ete-online.com/content/3/1/1
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itive associations. The most substantial change was the
additional data to support coherence, including a human
pathology study, laboratory studies showing that
benzo[a]pyrene, a known tobacco carcinogen, could pen-
etrate esophageal epithelial cells, and observations of
higher mortality in men than women and reduced mortal-
ity in populations with low smoking rates (Mormons and
7th Day Adventists). The 1982 report stated that the evi-
dence supported specificity, because the mortality ratio
for esophageal cancer differed from those of other smok-
ing related cancers, and that temporality was supported by
the availability of prospective studies and human pathol-
ogy studies suggesting pre-cancerous lesions. The 1982
Committee declared smoking to be a cause of esophageal
cancer, while the 1964 Committee had not made that
claim.
Bladder cancer: 1964 and 1982
Neither report made a causal claim for bladder cancer.
What new evidence was available in 1982 that remained
insufficient? By 1982 there were ten case-control studies
(compared with four in 1964) with a summary odds ratio
of 2.02 (95% CI: 1.74 – 2.34). Two of the six post-1964
studies failed to yield a statistically significant positive
result; however, there were more positive studies than in
1964. There were additional data to support coherence,
including observations of higher mortality in men than
women and reduced mortality in populations with low
A meta-analytic summary of the risk of cancer at four sites due to smoking, based on case-control studies from the Surgeon- General's reports of 1964 and 1982 Figure 1
A meta-analytic summary of the risk of cancer at four sites due to smoking, based on case-control studies from 
the Surgeon-General's reports of 1964 and 1982. Each bar shows a 95% confidence interval of the summary odds ratio, 
with the point estimate and 95% confidence limits marked. The width of each bar is proportional to the total sample size of the 
studies included in the meta-analysis for that site.Emerging Themes in Epidemiology 2006, 3:1 http://www.ete-online.com/content/3/1/1
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smoking rates (Mormons and 7th Day Adventists). The
1982 report described a lower order of specificity for blad-
der cancer compared with the three other cancers and
cited the existence of other factors etiologically related
with bladder cancer. The existence of prospective studies
provided evidence of temporality.
Contrast between esophageal and bladder cancers in 1982
A positive causal claim was made in 1982 for esophageal
but not bladder cancer. What accounted for this differ-
ence? The strength of association was stronger for esopha-
geal than for bladder cancer (pooled odds ratio of 3.11
versus 2.02 in case-control studies). Statistically signifi-
cant positive associations with smoking were found in all
epidemiologic studies of esophageal cancer (nine case-
control and seven cohort), and eight of 10 case-control
and all eight cohort studies of bladder cancer. Studies of
the effects of benzo[a]pyrene on esophageal cells and
studies of esophageal autopsy tissue were described, but
no such studies were cited for bladder cancer. For both
cancers, a sex differential in mortality rates consistent with
smoking habits and lower mortality in low and ex-smok-
ing populations were cited. The 1982 report also stated
that the evidence for specificity and temporality of the
association was weaker for bladder than for esophageal
cancer, because of the existence of other causes of bladder
cancer and the absence of human pathology studies show-
ing pre-malignant lesions in smokers.
How Were the causal criteria applied?
From the six case studies taken together, we can observe
that strength of association and coherence (especially
dose-response, biologic plausibility and consistency with
general patterns of disease and exposure) appeared to
carry the greatest weight in these causal inferences, while
consistency, although still a factor, appeared to carry less
weight (Table 1). Instances in which a positive causal
claim was made were supported by larger odds ratios;
'causal' cases each had an odds ratio greater than 3.0,
while odds ratios for 'non-causal' cases were each less than
3.0. However, consistency was not always stronger for
'causal' cases. For example, the epidemiologic evidence for
bladder cancer in 1982 (16 of 18 studies positive), which
did not result in a 'causal' judgment, was of equal or
greater consistency to that for laryngeal cancer in 1964 (14
of 17 studies positive), which did result in a 'causal' judg-
ment. Human pathology studies were available in all
'causal' cases, but not in any 'non-causal' cases. Dose-
response data were consistently weaker in 'non-causal' rel-
ative to 'causal' cases (i.e. weaker dose-response trends
and fewer studies demonstrating a dose-response trend).
Evidential support did not differ with regard to the avail-
ability of animal studies; in most cases, animal studies
were either not reported or failed to yield consistent find-
ings. Thus, while findings in animals were not important
for determining whether or not a causal conclusion could
be reached in these particular cases, we can still conclude
that the absence of such evidence was not a barrier to
causal inference. Indeed, overall biologic evidence, partic-
ularly from human pathology studies, seemed to play an
essential role in causal inference in these case studies, even
though the committees did not explicitly set out biologic
plausibility as a separate criterion distinct from coherence.
Despite their inclusion as causal criteria, temporality and
specificity were not cited at all in 1964, except in the case
of lung cancer. In 1982, the evidence for temporality and
specificity was described as weaker for bladder cancer than
for esophageal cancer.
Discussion
We analyzed the causal inferences of two expert commit-
tees with regard to smoking and lung, laryngeal, esopha-
geal, and bladder cancer, summarizing the evidence that
was available for each and making comparisons between
inferences. Strength of association and coherence
appeared to carry the most weight in the committees'
inferences, while consistency appeared to carry less
weight. Based on the committees' accounts of their evalu-
ation of the evidence, the criteria of temporality and spe-
cificity were not applied at all in some cases. Within the
category of coherence, evidence from human pathology
studies, localization of exposure, and mortality patterns
were highlighted. While the causal criteria are typically
linked with the discipline of epidemiology in particular,
they were applied to a range of different types of data and
by committees with a wide range of expertise; in fact, the
1964 committee included only one epidemiologist out of
ten members.
Based on the reports, it appears that the two committees
did not consistently apply the criteria they set out at the
start of their inquiries. In particular, although temporality
and specificity were included as criteria, they were not
referred to at all in the 1964 report with the exception of
lung cancer. These results add to previous findings that
authors of review papers apply causal criteria inconsist-
ently, often excluding or even altering criteria without giv-
ing reasons for these changes [29]. It is possible that some
criteria were used implicitly in the process of causal infer-
ence in the reports of the Surgeon General, but that their
application was not adequately described. For example,
while localization of cancer in the exposure pathway was
not specifically mentioned in either report with reference
to esophageal or bladder cancer, it may have played a role
(albeit not explicitly acknowledged in the reports) in the
failure to reach a causal conclusion for bladder cancer.
However, this ambiguity itself presents substantial diffi-
culties for communicating to others the evidential basis
for the committees' conclusions. The 1964 report is con-Emerging Themes in Epidemiology 2006, 3:1 http://www.ete-online.com/content/3/1/1
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sidered a landmark specifically because it applied explicit
pre-stated criteria for causal inference; the ability of these
criteria to help ensure objective, evidence-based decision
making is limited if their application is not sufficiently
transparent.
The process of synthesizing evidence and drawing causal
conclusions does not occur in isolation, of course, but
within a social and political context, and sometimes that
context, particularly in the case of smoking and lung can-
cer in 1964, is highly charged. Historians and sociologists
of science have presented evidence that extra-scientific val-
ues, such as ideology or personal gain, can influence how
scientists interpret evidence [30,31]. Additionally, extra-
scientific values have been acknowledged to play a role in
evidence-based public health, accounting in part for why
different expert groups sometimes reach divergent conclu-
sions based on identical evidence [32]. Other studies of
expert scientific committees have provided evidence that
scientific disagreements can to some degree be explained
by political and other factors [33-35].
Luther Terry attempted to minimize such influences by
limiting the committee's purview to reviewing the science,
excluding policy recommendations, and by carefully
selecting committee members who would not be per-
ceived to be in conflict. Nevertheless, it is reasonable to
ask whether the tobacco industry, which was challenging
the science and vigorously opposing tobacco regulation at
the time [36], could have influenced the committee's
actions. However, in the end the committee took a strong
position on the evidence linking smoking with lung and
laryngeal cancer. Both the 1964 and 1982 reports proba-
bly tended towards being conservative in their conclu-
sions merely as a result of the group process. There were
certainly other groups and influential individual scientists
who had arrived at the same causal conclusions much ear-
lier. However, tobacco industry opposition did not pre-
vent authors of the reports of the Surgeon General from
reaching causal conclusions based on the evidence. While
tobacco industry efforts to criticize the science may have
contributed to a more conservative stance overall, it seems
unlikely that they would explain the differences in out-
comes for different causal questions (i.e. lung versus blad-
der cancer).
The value of the causal criteria is that they provide explicit
guidelines for evaluating evidence which, in turn, help
reduce the influence of extra-scientific values and make
inferences as transparent as possible. However, when such
rules are applied inconsistently or without explicit
descriptions, there is greater scope for extra-scientific val-
ues to influence causal conclusions. The Royal College of
Physicians (RCP) had released its own expert committee
review on smoking and health in 1962, which concluded
that cigarette smoking is a cause of lung cancer but did not
claim causation for any other type of cancer. However, the
RCP did not cite any explicit guidelines for causal infer-
ence or provide a detailed analysis of the evidence for can-
cers other than lung cancer, making it difficult to assess
why they reached a different conclusion for laryngeal can-
cer from the 1964 Surgeon General's committee [37].
While this study suggests that use of the causal criteria
does not make inferences entirely transparent, application
of the criteria is certainly a major advance over not
employing any explicit inferential criteria. Efforts to fur-
ther clarify the meaning and application of the causal cri-
teria, as well as other methods for evaluating evidence,
may have substantial benefits for evidence-based medi-
cine. Additionally, because evidential synthesis involves
evidence from a range of disciplines, not only epidemiol-
ogy, other disciplines may benefit from further study of
inferential practices as well.
We are not suggesting that the behavior of these commit-
tees be held up as a "gold standard" or model to be emu-
lated. Indeed, the 1964 Surgeon General's report sets a
very high threshold for inferring causality, perhaps too
high for contemporary epidemiologic investigations of
modest effects and complex gene-environment interac-
tions. There are few situations where the evidence for cau-
sation is as overwhelming as it was for cigarette smoking
and lung cancer in 1964. In the cases we studied, for
example, no causal inferences were made where the
strength of association was less than 3.0. At the same time,
ecologic studies showing population level trends in ciga-
rette use and cancer mortality played an important role in
supporting the criterion of coherence, while such studies
appear to be given less weight by epidemiologists since
then [38].
The amount and type of evidence expected to support a
causal inference can change over time, as new scientific
methods become available and new disciplines develop.
Historians have suggested that the level of proof required
to demonstrate a causal link between smoking and lung
cancer was especially high in 1964, because the methods
of chronic disease epidemiology in use were new and not
well understood by scientists in other disciplines [39,40].
By 1982, epidemiologic methods had become more
widely used and the health effects of smoking were more
widely accepted by scientists and clinicians. But in spite of
this twenty year gap, the 1982 report still did not declare
a causal link between cigarette smoking and bladder can-
cer, demonstrating that the causal criteria continued to
play an essential role. Additionally, attitudes about the
role of potential conflicts of interest have changed over
time [41]. The 1964 committee explicitly excluded two
epidemiologic studies conducted and funded by a tobacco
company [27,28], arguing that these studies were vulner-Emerging Themes in Epidemiology 2006, 3:1 http://www.ete-online.com/content/3/1/1
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able to the "healthy worker" bias because they compared
disease rates among cigarette company workers with those
of the general population. While the sponsorship of these
studies was not raised as an issue, it likely would be today
[42].
Why study an episode from the past like this? We main-
tain that further case studies like this one, both contempo-
rary and historical, can raise new research questions and
provide essential information to allow epidemiologists
and other public health scientists to critically examine
application of causal criteria today. Our findings suggest
that the method of causal inference that has been articu-
lated in textbooks and in the Surgeon General reports is
incomplete, in that individual criteria and their joint
application can be open to multiple interpretations [43].
Thus, there are elements of practice that can only be
understood by observing how causal criteria are applied
in real situations. For example, in carrying out systematic
reviews, authors should clearly define and state the causal
criteria they are applying and consider whether they are all
to be given equal weight. Further studies investigating
more diverse applications of the causal criteria could
allow for broader generalizations about the type and level
of evidence required in practice for causal inferences in
evidence-based public health.
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